Department of Neurophysiology, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, 560029, India.
Departments of Neurology and Neuroscience, Yale University School of Medicine, New Haven, CT, USA.
Neurotox Res. 2021 Dec;39(6):1892-1907. doi: 10.1007/s12640-021-00439-6. Epub 2021 Nov 11.
Parkinson disease (PD) prevalence varies by ethnicity. In an earlier study, we replicated the reduced vulnerability to PD in an admixed population, using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-susceptible C57BL/6 J, MPTP-resistant CD-1 and their F1 crossbreds. In the present study, we investigated if the differences have a developmental origin. Substantia nigra was evaluated at postnatal days 2 (P2), P6, P10, P14, P18, and P22. C57BL/6 J mice had smaller nigra and fewer dopaminergic neurons than the CD-1 and crossbreds at P2, which persisted through development. A significant increase in numbers and nigral volume was observed across strains until P14. A drastic decline thereafter was specific to C57BL/6 J. CD-1 and crossbreds retained their numbers from P14 to stabilize with supernumerary neurons at adulthood. The neuronal size increased gradually to attain adult morphology at P10 in the resistant strains, vis-à-vis at P22 in C57BL/6 J. Accordingly, in comparison to C57BL/6 J, the nigra of CD-1 and reciprocal crossbreds possessed cytomorphological features of resilience, since birth. The considerably lesser dopaminergic neuronal loss in the CD-1 and crossbreds was seen at P2 and P14 and thereafter was complemented by attenuated developmental cell death. The differences in programmed cell death were confirmed by reduced TUNEL labelling, AIF, and caspase-3 expression. GDNF expression aligned with the cell death pattern at P2 and P14 in both nigra and striatum. Earlier maturity of nigra and its neurons appears to be better features that reflect as MPTP resistance at adulthood. Thus, variable MPTP vulnerability in mice and also differential susceptibility to PD in humans may arise early during nigral development.
帕金森病(PD)的患病率因种族而异。在早期的一项研究中,我们使用对 1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)敏感的 C57BL/6J、MPTP 抗性的 CD-1 及其 F1 杂交种,复制了混合人群中 PD 易感性降低的现象。在本研究中,我们研究了这些差异是否具有发育起源。在出生后第 2 天(P2)、P6、P10、P14、P18 和 P22 评估黑质。C57BL/6J 小鼠的黑质小于 CD-1 和杂交种,并且在 P2 时多巴胺能神经元数量较少,这种情况一直持续到发育过程中。在 P14 之前,所有品系的数量和黑质体积都显著增加。此后,C57BL/6J 急剧下降。CD-1 和杂交种从 P14 开始保留其数量,并在成年时稳定下来,同时具有多余的神经元。与 C57BL/6J 相比,抗性品系的神经元大小逐渐增加,至 P10 时达到成年形态,而 C57BL/6J 则在 P22 时达到成年形态。因此,与 C57BL/6J 相比,CD-1 和反向杂交种的黑质从出生起就具有弹性的细胞形态特征。在 P2 和 P14 以及此后,CD-1 和杂交种的多巴胺能神经元丢失较少,这是由发育性细胞死亡减少所补偿的。TUNEL 标记、AIF 和 caspase-3 表达证实了程序性细胞死亡的差异。GDNF 表达与 P2 和 P14 时黑质和纹状体的细胞死亡模式一致。黑质及其神经元的较早成熟似乎是更好的特征,反映了成年时对 MPTP 的抗性。因此,小鼠中 MPTP 易感性的差异以及人类中对 PD 的不同易感性可能在黑质发育早期就出现了。